Finally, based on this evidence, we hypothesized that if a metastasis suppressing IL-13-STAT6-TP63 signaling axis is activated in the absence of IL13Rα2 then STAT6 and TP63 expression levels may coordinately predict survival of patients with breast cancer. This evidence concerns the gene TP63 and breast carcinoma.